Related Experiment Video
Updated: Jun 30, 2025

Perturbing Endothelial Biomechanics via Connexin 43 Structural Disruption
Published on: October 4, 2019
Understanding COVID-19-associated endothelial dysfunction: role of PIEZO1 as a potential therapeutic target
Xiaoting Zhang1, Jinhai Liu1, Xiaoming Deng1
1Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China.
Insights
This review explores how PIEZO1, a mechanosensitive ion channel, may help treat COVID-19 by targeting endothelial dysfunction. Understanding PIEZO1
Area of Science:
- Cardiovascular Biology
- Infectious Diseases
- Molecular Medicine
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is a global health crisis.
- Endothelial dysfunction is increasingly recognized as a key factor in COVID-19-related multiorgan damage.
- Novel therapeutic targets for COVID-19-associated endothelial dysfunction are urgently needed.
Purpose of the Study:
- To review the potential role of the mechanosensitive ion channel PIEZO1 in COVID-19.
- To explore PIEZO1 as a therapeutic target for mitigating endothelial dysfunction in COVID-19 patients.
Main Methods:
- Literature review of studies on PIEZO1 function and COVID-19 pathophysiology.
- Analysis of emerging evidence linking PIEZO1 to inflammation, thrombosis, and endothelial integrity.
Main Results:
- PIEZO1 is highly expressed in blood vessels and regulates critical endothelial functions.
- Emerging data suggest PIEZO1 involvement in processes affected by SARS-CoV-2 infection.
- PIEZO1 modulation may offer a strategy to counteract COVID-19-induced endothelial damage.
Conclusions:
- PIEZO1 represents a promising therapeutic target for addressing endothelial dysfunction in COVID-19.
- Further research into PIEZO1's specific mechanisms in COVID-19 is warranted.
- Targeting PIEZO1 could lead to novel treatments for severe COVID-19 complications.
Abstract:
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Due to its high infectivity, the pandemic has rapidly spread and become a global health crisis. Emerging evidence indicates that endothelial dysfunction may play a central role in the multiorgan injuries associated with COVID-19. Therefore, there is an urgent need to discover and validate novel therapeutic strategies targeting endothelial cells. PIEZO1, a mechanosensitive (MS) ion channel highly expressed in the blood vessels of various tissues, has garnered increasing attention for its potential involvement in the regulation of inflammation, thrombosis, and endothelial integrity. This review aims to provide a novel perspective on the potential role of PIEZO1 as a promising target for mitigating COVID-19-associated endothelial dysfunction.
More Related Videos
07:56Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
Published on: May 5, 2023
06:35Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
Published on: April 27, 2016
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Regulation of Angiogenesis and Blood Supply
Mechanically-gated Ion Channels